您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > AST2818 mesylate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AST2818 mesylate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AST2818 mesylate图片
CAS NO:2130958-55-1
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
Alflutinib (Furmonertinib) mesylate 是一种有效的 EGFR 抑制剂。 Alflutinib (Furmonertinib) mesylate 抑制 EGFR 活性突变以及 T790M 获得性耐药突变。阿氟替尼(Furmonertinib)甲磺酸盐具有研究癌症疾病,尤其是非小细胞肺癌(NSCLC)的潜力。
Cas No.2130958-55-1
别名甲磺酸伏美替尼; Furmonertinib mesylate; AST2818 mesylate
Canonical SMILESC=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(CCN(C)C)C)=O.CS(=O)(O)=O
分子式C29H35F3N8O5S
分子量664.7
溶解度DMSO : 5 mg/mL (7.52 mM)
储存条件Store at -20°C,unstable in solution, ready to use.
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

AST2818 mesylate is an EGFR inhibitor.

AST2818 mesylate is designed to inhibit EGFR active mutations as well as the T790M acquired resistant mutation[1].

[1]. Y.Shi, et al. P2.03-028 Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Patients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial. J Thorac Oncol. 2017 Nov, 12(11): S2138.